Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Prefrontal-Accumbens Glutamate and Ethanol Escalation in Adolescent and Adult C57
PROJECT 1: Germ Cell Differentiation from Human iPSCs and hEScs
Oral Health of Older Adults
Regulation of Proenkephalin Gene Expression
Reversion of Ras Oncogene Mediated Cell Transformation
Recently added grants:
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
Integration of Genomic and Clinical Data to Enhance Subtyping of Colon Cancer
Regulation of Pancreatic Oncogenesis by the Gut Microbiome
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma
Immune Impact on Cancer Chemoresistance
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005125-001
Application #
6994810
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2004
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening, Reg
Sinicrope, Frank / University of Texas MD Anderson Cancer Center
$1,136,114
Comments
Be the first to comment on this grant